PREDICTIVE ONCOLOGY INC (POAI) Stock News
NASDAQ:POAI - Nasdaq - US74039M3097 - Common Stock - Currency: USD
POAI Latest News and Analysis
Predictive Oncology Partners with Switzerland-Based Tecan Group Ltd. to Expand High-Throughput Drug Screening to Include Human Tumor Spheroids Using Automated Imaging and 3D Analysis
Study used Predictive Oncology’s vast biobank of cryopreserved live cell tumor specimens for the production and testing of primary patient tumor spheroids ...
Gapping stocks in Wednesday's session
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the gap up and gap down stocks in today's session.
Predictive Oncology Announces Planned European Launch of its ChemoFx® Treatment Selection Marker and Tumor Profiling Assay
Predictive Oncology Announces Planned European Launch of its ChemoFx® Treatment Selection Marker and Tumor Profiling Assay
Initial plans target European clinical trials while providing standard testing to clinicians for individual patients There are an estimated 250,000...
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates LBRDA, NARI, ML, POAI on Behalf of Shareholders
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates RHE, FUBO, POAI on Behalf of Shareholders
Renovaro Issues Shareholder Letter and Provides Corporate Update
POAI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Predictive Oncology Inc. Is Fair to Shareholders
Renovaro to Acquire Predictive Oncology in All-Stock Transaction
Predictive Oncology Announces Agreement to be Acquired by Renovaro
Predictive Oncology Announces Agreement to be Acquired by Renovaro
- Combination creates immediate scientific synergies by harnessing complementary AI / ML platforms to improve patient outcomes across multiple cancer...
Predictive Oncology Announces Progress in Ongoing Evaluation of Strategic Alternatives
Predictive Oncology Announces Progress in Ongoing Evaluation of Strategic Alternatives
PITTSBURGH, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, today announced progress in...
This SolarEdge Technologies Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday
Predictive Oncology Reports Third Quarter 2024 Financial Results and Provides Strategic Update
Company initiates process to explore a broad range of strategic alternatives to maximize shareholder value
Predictive Oncology Reports Third Quarter 2024 Financial Results and Provides Strategic Update
Company initiates process to explore a broad range of strategic alternatives to maximize shareholder value...
Predictive Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Predictive Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference
PITTSBURGH, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, is scheduled...
Predictive Oncology Study Demonstrates Long-Term Stability and Viability of Proprietary Biobank of Primary Tumor Specimens for Pharmaceutical Drug Discovery
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Q2 2024 Financial Results, Provides Business Update
Predictive Oncology (NASDAQ: POAI) today announced its financial and operating results for the second quarter ended June 30, 2024, and provided a corporate update. The company reported a net loss of approximately $3.2 million on total revenue of approximately $0.3 million for the quarter. In addition, it concluded Q2 2024 with $5.3 million of cash […]
Predictive Oncology Reports Second Quarter 2024 Financial Results and Provides Business Update
Company to host investor call and webcast today, August 14th, at 8:30am EDT
Predictive Oncology Reports Second Quarter 2024 Financial Results and Provides Business Update
Company to host investor call and webcast today, August 14th, at 8:30am EDT...
POAI Stock Earnings: Predictive Oncology Reported Results for Q2 2024
Predictive Oncology just reported results for the second quarter of 2024.
POAI Stock Earnings: Predictive Oncology Reported Results for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Predictive Oncology (NASDAQ:POAI) just reported results for the second quarter ...
Predictive Oncology Expands the Application of its Live-Cell Tumor Platform to De-Risk Drug Discovery and Accelerate Pipeline Development
Predictive Oncology to Report Second Quarter 2024 Financial Results on Wednesday, August 14, 2024
Management to host conference call and webcast at 8:30am ET
Predictive Oncology to Report Second Quarter 2024 Financial Results on Wednesday, August 14, 2024
Management to host conference call and webcast at 8:30am ET...
Predictive Oncology Announces Exercise of Warrants for $1.26 Million Gross Proceeds
Predictive Oncology Announces Exercise of Warrants for $1.26 Million Gross Proceeds
PITTSBURGH, July 26, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, today...
Why Is Predictive Oncology (POAI) Stock Up 70% Today?
Predictive Oncology’s AI-driven platform demonstrated predictive utility in oncology, thereby providing credibility to POAI stock.